Primary cardiac amyloidosis with 20-year survival

Michael E. Fealey, William D. Edwards, Martha Grogan, Angela Dispenzieri

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: The natural history of primary amyloidosis is poor, and for patients with symptomatic cardiac involvement, survival is generally less than 6 months. Even among treated patients with amyloid heart disease, survival beyond 5 years is rare. Case report: We report a patient with primary cardiac amyloidosis who is currently alive 20 years after his initial diagnosis. The extent and subtype of amyloid were documented by endomyocardial biopsy both at the time of initial diagnosis and 20 years later. To our knowledge, this is the longest survival ever reported for a patient with cardiac involvement by primary amyloidosis. Conclusion: The remarkably long stabilization of amyloid deposition in this patient may be attributed to early diagnosis, early institution of therapy, and, possibly, favorable genetic factors.

Original languageEnglish (US)
Pages (from-to)331-335
Number of pages5
JournalCardiovascular Pathology
Volume15
Issue number6
DOIs
StatePublished - Nov 2006

Fingerprint

Survival
Amyloid
Secondary Prevention
Natural History
Early Diagnosis
Heart Diseases
Primary amyloidosis
Biopsy

Keywords

  • Amyloidosis
  • Endomyocardial biopsy
  • Heart failure

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pathology and Forensic Medicine

Cite this

Primary cardiac amyloidosis with 20-year survival. / Fealey, Michael E.; Edwards, William D.; Grogan, Martha; Dispenzieri, Angela.

In: Cardiovascular Pathology, Vol. 15, No. 6, 11.2006, p. 331-335.

Research output: Contribution to journalArticle

Fealey, Michael E. ; Edwards, William D. ; Grogan, Martha ; Dispenzieri, Angela. / Primary cardiac amyloidosis with 20-year survival. In: Cardiovascular Pathology. 2006 ; Vol. 15, No. 6. pp. 331-335.
@article{6dcbb4d7a5654145b30862d567063cc5,
title = "Primary cardiac amyloidosis with 20-year survival",
abstract = "Background: The natural history of primary amyloidosis is poor, and for patients with symptomatic cardiac involvement, survival is generally less than 6 months. Even among treated patients with amyloid heart disease, survival beyond 5 years is rare. Case report: We report a patient with primary cardiac amyloidosis who is currently alive 20 years after his initial diagnosis. The extent and subtype of amyloid were documented by endomyocardial biopsy both at the time of initial diagnosis and 20 years later. To our knowledge, this is the longest survival ever reported for a patient with cardiac involvement by primary amyloidosis. Conclusion: The remarkably long stabilization of amyloid deposition in this patient may be attributed to early diagnosis, early institution of therapy, and, possibly, favorable genetic factors.",
keywords = "Amyloidosis, Endomyocardial biopsy, Heart failure",
author = "Fealey, {Michael E.} and Edwards, {William D.} and Martha Grogan and Angela Dispenzieri",
year = "2006",
month = "11",
doi = "10.1016/j.carpath.2006.06.002",
language = "English (US)",
volume = "15",
pages = "331--335",
journal = "Cardiovascular Pathology",
issn = "1054-8807",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Primary cardiac amyloidosis with 20-year survival

AU - Fealey, Michael E.

AU - Edwards, William D.

AU - Grogan, Martha

AU - Dispenzieri, Angela

PY - 2006/11

Y1 - 2006/11

N2 - Background: The natural history of primary amyloidosis is poor, and for patients with symptomatic cardiac involvement, survival is generally less than 6 months. Even among treated patients with amyloid heart disease, survival beyond 5 years is rare. Case report: We report a patient with primary cardiac amyloidosis who is currently alive 20 years after his initial diagnosis. The extent and subtype of amyloid were documented by endomyocardial biopsy both at the time of initial diagnosis and 20 years later. To our knowledge, this is the longest survival ever reported for a patient with cardiac involvement by primary amyloidosis. Conclusion: The remarkably long stabilization of amyloid deposition in this patient may be attributed to early diagnosis, early institution of therapy, and, possibly, favorable genetic factors.

AB - Background: The natural history of primary amyloidosis is poor, and for patients with symptomatic cardiac involvement, survival is generally less than 6 months. Even among treated patients with amyloid heart disease, survival beyond 5 years is rare. Case report: We report a patient with primary cardiac amyloidosis who is currently alive 20 years after his initial diagnosis. The extent and subtype of amyloid were documented by endomyocardial biopsy both at the time of initial diagnosis and 20 years later. To our knowledge, this is the longest survival ever reported for a patient with cardiac involvement by primary amyloidosis. Conclusion: The remarkably long stabilization of amyloid deposition in this patient may be attributed to early diagnosis, early institution of therapy, and, possibly, favorable genetic factors.

KW - Amyloidosis

KW - Endomyocardial biopsy

KW - Heart failure

UR - http://www.scopus.com/inward/record.url?scp=33750942309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750942309&partnerID=8YFLogxK

U2 - 10.1016/j.carpath.2006.06.002

DO - 10.1016/j.carpath.2006.06.002

M3 - Article

VL - 15

SP - 331

EP - 335

JO - Cardiovascular Pathology

JF - Cardiovascular Pathology

SN - 1054-8807

IS - 6

ER -